Company comparison

Exscientia vs Ansys

Radar profile, momentum bars, and stack placement side by side.

← Back to Compare

Exscientia
Not scored
momentum
Ansys
Not scored
momentum
Exscientia capital
—
Ansys capital
—
No radar series.

Momentum head-to-head

    Attribute tape

    FieldExscientiaAnsys
    CategoryVertical applicationsVertical applications
    StackLayer 9Layer 9
    HQOxford, United KingdomCanonsburg, PA, United States
    Founded20121970
    StatusAcquiredAcquired
    Funding——
    Momentum——
    SummaryExscientia is an AI-driven pharmatech company that uses machine learning and automated experimental biology to design small-molecule drug candidates, operating a closed-loop design-make-test-learn platform. It claims to be the first company to advance AI-designed small molecules into human clinical trials, and was acquired by Recursion Pharmaceuticals in late 2024.Ansys develops engineering simulation software spanning structural mechanics, computational fluid dynamics, electromagnetics, and optics, enabling engineers to validate product designs digitally before physical prototyping. As of 2025, Ansys operates as a subsidiary of Synopsys following its acquisition.
    Who forTeams evaluating AI vendors in this category.Teams evaluating AI vendors in this category.
    DifferentiatorExscientia is an AI-driven pharmatech company that uses machine learning and automated experimental biology to design small-molecule drug candidates, operating a closed-loop design-make-test-learn platform. It claims to be the first company to advance AI-designed small molecules into human clinical trials, and was acquired by Recursion Pharmaceuticals in late 2024.Ansys develops engineering simulation software spanning structural mechanics, computational fluid dynamics, electromagnetics, and optics, enabling engineers to validate product designs digitally before physical prototyping. As of 2025, Ansys operates as a subsidiary of Synopsys following its acquisition.
    Open ExscientiaOpen Ansys